Lexaria's strategy is to continue developing and optimizing our wholly-owned DehydraTECH™ drug delivery platform for application in the GLP-1 space, positioning it as a 'must-have' technology for ...

BusinessWire India Mumbai Maharashtra Hyderabad Telangana [India] October 30 PopVax an Indian full-stack biotechnology ...

PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using computational protein design, is pleased to announce that its ongoing research effort to ...

(RTTNews) - Vera Therapeutics Inc. (VERA) announced results from its ORIGIN Phase 2b trial of atacicept in immunoglobulin A nephropathy or IgAN, demonstrating stabilized kidney function over 96 ...

Oppenheimer analyst Jay Olson maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) today and set a price target of $70.00. The company’s shares closed yesterday at $15.85.

The recommendation comes just one month after Novo entered into a multi-year partnership with NanoVation Therapeutics to advance genetic medicines for cardiometabolic and rare diseases. The deal, ...

Nanovation Therapeutics, Olympus Medical, Pulmonx, Roche Diagnostics, and Uptake Medical. Korn has received research support from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GSK, Novartis, ...

PHILADELPHIA - Century Therapeutics, a biotechnology firm focused on developing cell therapies, has shared interim results from its Phase 1 ELiPSE-1 study of CNTY-101 in patients ...

Terray Therapeutics has raked in $120 million for a series B fundraise as the AI-focused biotech aims to transform small molecule drug development. New investor Bedford Ridge Capital and existing ...

Messenger RNA–based therapeutics and vaccines are the new hope in the fight against incurable diseases. A commonly used strategy in the development of messenger RNA (mRNA) medicine is based on ...